Selective TRAIL-Induced Apoptosis in Dysplastic Neoplasia of the Colon May Lead to New Neoadjuvant or Adjuvant Therapies

Niklas Finnberg,Wafik S El-Deiry

doi:10.1158/1078-0432.ccr-06-0567

Selective TRAIL-Induced Apoptosis in Dysplastic Neoplasia of the Colon May Lead to New Neoadjuvant or Adjuvant Therapies

Niklas Finnberg, Wafik S El-Deiry

Open Access

https://doi.org/10.1158/1078-0432.ccr-06-0567

Copy DOI

Journal: Clinical Cancer Research	Publication Date: Jul 15, 2006
Citations: 13

Affiliation: Translational Therapeutics (United States), Molecular Oncology (United States), University of Pennsylvania

#Tumor Necrosis Factor )–related Apoptosis-inducing Ligand #Recombinant Human Tumor Necrosis Factor + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

In this issue of Clinical Cancer Research , Jalving et al. ([1][1]) shows that treatment with recombinant human tumor necrosis factor (TNF)–related apoptosis-inducing ligand (TRAIL) triggers apoptosis in human dysplastic colorectal adenomas of the colon. These observations suggest the potential to

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Clinical Cancer Research

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.